Financhill
Sell
22

BEAT Quote, Financials, Valuation and Earnings

Last price:
$2.24
Seasonality move :
-33.73%
Day range:
$2.17 - $2.40
52-week range:
$1.35 - $3.48
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
12.44x
Volume:
205.2K
Avg. volume:
237.6K
1-year change:
-6.67%
Market cap:
$59.7M
Revenue:
--
EPS (TTM):
-$0.68

Analysts' Opinion

  • Consensus Rating
    HeartBeam has received a consensus rating of Leans Bullish. The company's average rating is a Leans Bullish based on 1 Buy rating, 1 Hold rating, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $5.00, HeartBeam has an estimated upside of 123.21% from its current price of $2.24.
  • Price Target Downside
    According to analysts, the lowest downside price target is $2.00 representing 100% downside risk from its current price of $2.24.

Fair Value

  • According to the consensus of 2 analysts, HeartBeam has 123.21% upside to fair value with a price target of $5.00 per share.

BEAT vs. S&P 500

  • Over the past 5 trading days, HeartBeam has underperformed the S&P 500 by -4.23% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • HeartBeam does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • HeartBeam has grown year-over-year revenues for 0 quarters straight. In the most recent quarter HeartBeam reported revenues of --.

Earnings Growth

  • HeartBeam has grown year-over-year earnings for 0 quarters straight. In the most recent quarter HeartBeam reported earnings per share of -$0.19.
Enterprise value:
54M
EV / Invested capital:
--
Price / LTM sales:
--
EV / EBIT:
--
EV / Revenue:
--
PEG ratio (5yr expected):
--
EV / Free cash flow:
-4.00x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
--
Net Income Margin (TTM):
--
Return On Equity:
--
Return On Invested Capital:
--
Operating Margin:
--
Trailing 12 Months Fiscal Quarters
Period Ending 2022-09-30 2023-09-30 2024-09-30 2023-09-30 2024-09-30
Income Statement
Revenue -- -- -- -- --
Gross Profit -- -- -- -- --
Operating Income -$10.6M -$14.9M -$19.1M -$3.7M -$5.1M
EBITDA -$10.6M -$14.9M -$19.1M -$3.7M -$5.1M
Diluted EPS -$1.41 -$1.24 -$0.68 -$0.13 -$0.19
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Balance Sheet
Current Assets -- $961K $6.7M $19.5M $6.1M
Total Assets -- $961K $6.7M $19.6M $6.7M
Current Liabilities -- $6.1M $932K $1M $1.9M
Total Liabilities -- $6.1M $932K $1M $1.9M
Total Equity -- -$5.2M $5.7M $18.6M $4.8M
Total Debt -- -- -- -- --
Trailing 12 Months Fiscal Quarters
Period Ending 2022-09-30 2023-09-30 2024-09-30 2023-09-30 2024-09-30
Cash Flow Statement
Cash Flow Operations -$9.4M -$12.2M -$13.2M -$2.1M -$3.3M
Cash From Investing -- -$144K -$313K $3.8M -$103K
Cash From Financing $15.2M $25M $105K $111K $21K
Free Cash Flow -$9.4M -$12.2M -$13.5M -$2.2M -$3.4M
BEAT
Sector
Market Cap
$59.7M
$49.2M
Price % of 52-Week High
64.37%
48.57%
Dividend Yield
0%
0%
Shareholder Yield
--
-0.74%
1-Year Price Total Return
-6.67%
-30.94%
Beta (5-Year)
--
0.754
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Technicals

8-day SMA
Sell
Level $2.31
200-day SMA
Sell
Level $2.39
Bollinger Bands (100)
Sell
Level 2.12 - 2.7
Chaikin Money Flow
Buy
Level 10.8M
20-day SMA
Sell
Level $2.65
Relative Strength Index (RSI14)
Sell
Level 37.78
ADX Line
Sell
Level 39.3
Williams %R
Buy
Level -93.9394
50-day SMA
Sell
Level $2.60
MACD (12, 26)
Sell
Level -0.13
25-day Aroon Oscillator
Sell
Level -36
On Balance Volume
Neutral
Level 240.9M

Financial Scores

--
Altman Z-Score (Annual)
Level (--)
--
CA Score (Annual)
Level (--)
--
Beneish M-Score (Annual)
Level (--)
Buy
Momentum Score
Level (10)
--
Ohlson Score
Level (--)
--
Piotroski F Score (Annual)
Level (--)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)

Revenue Forecast

Earnings per Share Forecast

Company Profile

HeartBeam Inc is a medical technology company primarily focusing on developing and commercializing higher resolution ambulatory Electrocardiogram ("ECG") solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The Company’s ability to develop higher-resolution ECG solutions is achieved through the development of the Company’s proprietary and patented Vector Electrocardiography ("VECG") technology platform. The Company has validated this technology and is seeking U.S. Food and Drug Administration ("FDA") clearance for its initial telehealth products.

Stock Forecast FAQ

In the current month, BEAT has received 1 Buy ratings 1 Hold ratings, and 0 Sell ratings. The BEAT average analyst price target in the past 3 months is $5.00.

  • Where Will HeartBeam Stock Be In 1 Year?

    According to analysts, the consensus estimate is that HeartBeam share price will rise to $5.00 per share over the next 12 months.

  • What Do Analysts Say About HeartBeam?

    Analysts are divided on their view about HeartBeam share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that HeartBeam is a Sell and believe this share price will drop from its current level to $2.00.

  • What Is HeartBeam's Price Target?

    The price target for HeartBeam over the next 1-year time period is forecast to be $5.00 according to 2 Wall Street analysts, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.

  • Is BEAT A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for HeartBeam is a Leans Bullish. 1 of 2 analysts rates the stock a Leans Bullish at this time.

  • How Can I Buy Shares Of BEAT?

    You can purchase shares of HeartBeam via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase HeartBeam shares.

  • What Is The HeartBeam Share Price Today?

    HeartBeam was last trading at $2.24 per share. This represents the most recent stock quote for HeartBeam. Yesterday, HeartBeam closed at $2.24 per share.

  • How To Buy HeartBeam Stock Online?

    In order to purchase HeartBeam stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

What Companies Are In The VanEck Semiconductor ETF?
What Companies Are In The VanEck Semiconductor ETF?

There’s a lot to love about the VanEck Semiconductor ETF,…

How High Can Palantir Stock Go?
How High Can Palantir Stock Go?

Palantir Technologies (NASDAQ:PLTR) has been one of the undisputed victors…

Will This ETF Beat the Market Over the Next 12 Months?
Will This ETF Beat the Market Over the Next 12 Months?

2024 was another banner year for the US stock market,…

Stock Ideas

Sell
48
Is AAPL Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 40x

Buy
56
Is NVDA Stock a Buy?

Market Cap: $3.5T
P/E Ratio: 121x

Sell
46
Is MSFT Stock a Buy?

Market Cap: $3.1T
P/E Ratio: 36x

Alerts

Sell
39
DOGZ alert for Jan 4

Dogness (International) [DOGZ] is down 20.52% over the past day.

Buy
66
DMRC alert for Jan 4

Digimarc [DMRC] is up 16.19% over the past day.

Sell
39
MSTR alert for Jan 4

MicroStrategy [MSTR] is up 13.33% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock